Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Behringer · SciRah

Researcher profile · Semantic Scholar

K. Behringer

Share profile

K. Behringer — researcher profile on SciRah

h-index: 26
Works: 97
Citations: 2,840

Most-cited papers

Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
K. Behringer, K. Breuer, T. Reineke, M. May +6 more
2005Journal of Clinical Oncology287 citations
Semantic Scholar
Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
K. Behringer, H. Mueller, H. Goergen, Indra Thielen +16 more
2013Journal of Clinical Oncology243 citations Open access
Semantic Scholar
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
K. Behringer, H. Goergen, F. Hitz, J. Zijlstra +32 more
2015The Lancet167 citations
Semantic Scholar
No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group.
K. Behringer, L. Wildt, H. Mueller, V. Mattle +8 more
2010Annals of Oncology165 citations Open access
Semantic Scholar
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group.
D. Eichenauer, Indra Thielen, H. Haverkamp, J. Franklin +11 more
2014Blood134 citations Open access
Semantic Scholar
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial.
P. Borchmann, J. Ferdinandus, G. Schneider, A. Moccia +46 more
2024The Lancet119 citations Open access
Semantic Scholar
Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials.
M. Sieniawski, Thorsten Reineke, A. Josting, L. Nogova +5 more
2008Annals of Oncology114 citations Open access
Semantic Scholar
Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.
B. Böll, H. Goergen, K. Behringer, P. Bröckelmann +11 more
2016Blood113 citations
Semantic Scholar
From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential.
D. Ré, Roman K. Thomas, K. Behringer, V. Diehl
2005Blood109 citations
Semantic Scholar
Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group.
S. Kreissl, H. Mueller, H. Goergen, Axel Mayer +12 more
2016The Lancet Oncology106 citations
Semantic Scholar
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
D. Eichenauer, A. Plütschow, S. Kreissl, M. Sökler +13 more
2017The Lancet Oncology102 citations
Semantic Scholar
Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial.
K. Behringer, Indra Thielen, H. Mueller, H. Goergen +13 more
2012Annals of Oncology102 citations Open access
Semantic Scholar
Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation
A. Schüring, T. Fehm, K. Behringer, M. Goeckenjan +5 more
2017Archives of Gynecology and Obstetrics97 citations Open access
Semantic Scholar
Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration.
K. Behringer, H. Goergen, H. Müller, Indra Thielen +13 more
2016Journal of Clinical Oncology93 citations
Semantic Scholar
Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group.
D. Eichenauer, A. Plütschow, M. Fuchs, B. von Tresckow +6 more
2015Journal of Clinical Oncology92 citations
Semantic Scholar
Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) – Recommendations and Statements for Girls and Women
R. Dittrich, S. Kliesch, A. Schüring, M. Balcerek +53 more
2018Geburtshilfe und Frauenheilkunde79 citations Open access
Semantic Scholar
Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group.
K. Behringer, A. Josting, P. Schiller, H. Eich +3 more
2004Annals of Oncology79 citations Open access
Semantic Scholar
Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group.
B. Klimm, T. Reineke, H. Haverkamp, K. Behringer +5 more
2005Journal of Clinical Oncology76 citations
Semantic Scholar
Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study group.
B. Böll, H. Goergen, Nils Arndt, J. Meissner +12 more
2013Journal of Clinical Oncology62 citations Open access
Semantic Scholar
Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group.
S. Kreissl, H. Müller, H. Goergen, J. Meissner +14 more
2020Journal of Clinical Oncology43 citations
Semantic Scholar
Targeted Beacopp Variants In Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Interim Results Of a Randomized Phase II Study
P. Borchmann, D. Eichenauer, A. Pluetschow, H. Haverkamp +11 more
201339 citations
Semantic Scholar
Female fertility after cytotoxic therapy – protection of ovarian function during chemotherapy of malignant and non‐malignant diseases
V. Mattle, K. Behringer, A. Engert, L. Wildt
2005European journal of haematology. Supplementum38 citations
Semantic Scholar
Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group
K. Behringer, H. Müller, H. Görgen, Hans-Henning Flechtner +9 more
2013British Journal of Cancer37 citations Open access
Semantic Scholar
Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group
D. Eichenauer, H. Goergen, A. Plütschow, Diana Wongso +10 more
2016Leukemia31 citations
Semantic Scholar
Lymphocyte‐predominant and classical Hodgkin's lymphoma – comparison of outcomes
L. Nogova, T. Reineke, A. Josting, H. Mullerhermelink +5 more
2005European journal of haematology. Supplementum28 citations
Semantic Scholar
Could BEACOPP Be the New Standard for the Treatment of Advanced Hodgkin's Lymphoma (HL)?
V. Diehl, K. Behringer
2006Cancer Investigation26 citations
Semantic Scholar
Hodgkin's lymphoma in adults: diagnosis, treatment and follow-up.
M. Rancea, A. Engert, B. von Tresckow, T. Halbsguth +2 more
2013Deutsches Ärzteblatt International24 citations Open access
Semantic Scholar
Survivors’ perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study Group
S. Kreissl, H. Goergen, H. Müller, J. Meissner +6 more
2018Leukemia and Lymphoma23 citations
Semantic Scholar
Twenty‐five years clinical trials of the German Hodgkin Study Group (GHSG)
K. Behringer, V. Diehl
2005European journal of haematology. Supplementum19 citations
Semantic Scholar
Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study.
P. Borchmann, D. Eichenauer, A. Pluetschow, H. Haverkamp +11 more
2016Clinical advances in hematology & oncology : H&O18 citations
Semantic Scholar
Correlation Between Progression-Free and Overall Survival in Patients with Hodgkin Lymphoma: A Comprehensive Analysis of Individual Patient Data from Randomized GHSG Trials.
P. Bröckelmann, H. Müller, M. Fuchs, S. Gillessen +15 more
2024Annals of Oncology16 citations Open access
Semantic Scholar
Could BEACOPP Be the New Standard for the Treatment of Advanced Hodgkin's Lymphoma?
V. Diehl, K. Behringer
2006Cancer Investigation14 citations
Semantic Scholar
German Hodgkin Study Group Phase I Trial Of Doxorubicin, Vinblastine, Dacarbazine, and Lenalidomide (AVD-Rev) For Older Hodgkin Lymphoma Patients
A. Plütschow, M. Fuchs, D. Eichenauer, Indra Thielen +9 more
201313 citations
Semantic Scholar
Salvage Therapy of Refractory Chronic Disseminated Candidiasis in a Patient with Acute Myeloid Leukaemia and Secondary Prophylaxis During Allogeneic Stem Cell Transplantation
J. Vehreschild, Karsten Krüger, O. Kurzai, C. Wickenhauser +3 more
2006Mycoses (Berlin)13 citations Open access
Semantic Scholar
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial.
J. Ferdinandus, G. Schneider, A. Moccia, Richard Greil +25 more
2025The Lancet Oncology12 citations Open access
Semantic Scholar
Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced stage Hodgkin Lymphoma: results from the randomized international GHSG HD18 trial.
J. Ferdinandus, H. Müller, C. Damaschin, A. Jacob +17 more
2023Annals of Oncology11 citations Open access
Semantic Scholar
German Hodgkin's Lymphoma Study Group trials: lessons from the past and current strategies.
A. Draube, K. Behringer, V. Diehl
2006Clinical Lymphoma & Myeloma10 citations
Semantic Scholar
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
S. Sasse, H. Goergen, A. Plütschow, B. Böll +13 more
2018Journal of Clinical Oncology9 citations Open access
Semantic Scholar
Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients – An Analysis of GHSG HD14- and HD17-Patients
J. Rosenbrock, Andrés Vásquez-Torres, H. Mueller, K. Behringer +10 more
2021Frontiers in Oncology8 citations Open access
Semantic Scholar
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy.
P. Bröckelmann, H. Müller, T. Guhl, K. Behringer +10 more
2020Journal of Clinical Oncology7 citations Open access
Semantic Scholar
Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group
P. Bröckelmann, H. Goergen, M. Fuchs, J. Kříž +17 more
2015British Journal of Haematology7 citations Open access
Semantic Scholar
Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center
J. Momotow, H. Goergen, K. Behringer, P. Bröckelmann +5 more
2019HemaSphere6 citations Open access
Semantic Scholar
Treatment of Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): An Analysis from the German Hodgkin Study Group (GHSG)
D. Eichenauer, A. Pluetschow, M. Fuchs, K. Behringer +5 more
20145 citations
Semantic Scholar
Secondary MDS/AML In Hodgkin Lymphoma Patients Treated within German Hodgkin Study Group (GHSG) Clinical Trials After Introduction of the BEACOPP Protocol
D. Eichenauer, H. Haverkamp, K. Behringer, T. Halbsguth +4 more
20105 citations
Semantic Scholar
[Secondary malignancies after successful primary treatment of malignant Hodgkin's lymphoma].
P. Borchmann, K. Behringer, Andreas Josting, J. Rueffer +5 more
2006Der Pathologe5 citations
Semantic Scholar
Secondary Amenorrhoea after Hodgkin’s Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives during Therapy: A Report from the German Hodgkin Lymphoma Study Group (GHSG).
K. Behringer, K. Breuer, T. Reineke, M. May +4 more
20045 citations
Semantic Scholar
Patient-reported outcomes in Hodgkin lymphoma trials: a systematic review
Esther Natalie Oliva, T. Ionova, Edward Laane, M. Csenar +6 more
2024Frontiers in Oncology3 citations Open access
Semantic Scholar
Pregnancies and Childbirth Following Advanced-Stage Hodgkin Lymphoma Treatment with Brecadd or Beacopp in the Randomized Phase III GHSG HD21 Trial
J. Ferdinandus, G. Schneider, A. Fosså, A. Moccia +19 more
2023Blood3 citations Open access
Semantic Scholar
Infradiaphragmatic Hodgkin Lymphoma In Patients Treated With State-Of-The-Art Therapies: A Risk Factor Analysis From The German Hodgkin Study Group (GHSG) HD13 and HD14 Trials
B. von Tresckow, H. Görgen, A. Plütschow, B. Böll +7 more
20133 citations
Semantic Scholar
Fertility and Gonadal Function After Treatment of Early Unfavorable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG)
K. Behringer, Indra Thielen, H. Mueller, H. Goergen +7 more
20113 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Engert×32
Invite
A. Engert — researcher profile on SciRah
P. Borchmann×30
Invite
P. Borchmann — researcher profile on SciRah
V. Diehl×25
Invite
V. Diehl — researcher profile on SciRah
M. Fuchs×24
Invite
M. Fuchs — researcher profile on SciRah

×17

Invite

D. Eichenauer — researcher profile on SciRah

B. von Tresckow×16

Invite

B. von Tresckow — researcher profile on SciRah

Invite

H. Goergen — researcher profile on SciRah

T. Halbsguth×12

Invite

T. Halbsguth — researcher profile on SciRah

J. Meissner×10

Invite

J. Meissner — researcher profile on SciRah

Invite

B. Böll — researcher profile on SciRah

Invite

H. Eich — researcher profile on SciRah

Invite

S. Kreissl — researcher profile on SciRah